Knocking down HOIL-1 significantly impaired the HBV-HCC cell growth, migration and cancer stem cell (CSC) properties in vitro and inhibited tumor progression in an HBV-HCC mouse model. Here, RBCK1 is linked to hepatocellular carcinoma.